All In MedTech

Device Trial Radar · NCT02277990

World-wide Randomized Antibiotic Envelope Infection Prevention Trial

Cardiac Implantable Electronic Device (CIED) Antibiotic Envelope Infection Prevention Trial

Last checked: Nov 19, 2026Latest source record: Nov 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 7,075 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

7,075

Actual

Start

Jan 2015

Primary completion

Sep 2018

Study completion Sep 2018

Sponsor

Sponsor type
Industry
Collaborators
The Cleveland Clinic
First posted
Oct 29, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Medtronic , Inc. is sponsoring the World-wide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT), a randomized, prospective, multi-center, single blinded, post-market, interventional clinical study. This study will evaluate the ability of the TYRX™ envelope to reduce major Cardiac Implantable Electronic Device (CIED) infections through 12-months post-procedure following CIED generator replacement, upgrade, revision, or de novo cardiac resynchronization therapy defibrillator (CRT-D) implant. Additionally, this large device study provides the unique opportunity to prospectively characterize the performance of Medtronic's lead monitoring features in subjects whose CIED system includes a transvenous right ventricular (RV) defibrillation lead. Finally, the WRAP-IT study will serve as a post-approval study for those geographies requiring a post-approval study of the TYRX™ envelope.

Conditions

  • CIED Related Infection

Interventions

  • TYRX™ Absorbable Antibacterial EnvelopeDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 12 Month Kaplan-Meier Estimate of Major CIED Infection RateTime frame: Implant to 12 months

Locations

181 sites in 25 countries. Site status is shown where the registry gives one.

  • Alaska Heart Institute

    Anchorage, Alaska

  • Tri-City Cardiology Consultants

    Mesa, Arizona

  • Arizona Arrhythmia Consultants

    Scottsdale, Arizona

178 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.